54gene is an African genomics company building the world’s largest pan-African biobank. The company was founded in 2019 by Dr. Abasi Ene-Obong to unlock the African genome and improve our understanding of the world’s most genetically diverse population.
54gene is partnering with hospitals and research institutions in African countries; and with pharmaceutical and biotechnology companies to address the challenge of limited diverse genomics data, which may hold the key to medical discoveries and new healthcare solutions.
Backed by investors including Y Combinator, Fifty Years Ventures, Better Ventures, and KdT Ventures, 54gene aims to equilibrate healthcare for people of African origin while advancing the quality of medical care worldwide.
Abasi Ene-Obong PhD
Chief Executive Officer
Chief Operations Officer
Chief Commercial Officer
Chief of Staff
VP of Engineering & Head of Technology, Africa
VP of Diagnostics & Country Head, Nigeria
Dr. Zara Modibbo
VP Laboratory OperationsHead of Clinical Laboratory Services, Africa
VP Research Planning & Ethics
Dr. Jumi Popoola
Director of Scientific Services, Africa
Dr. Nabila Ado Wanka
Head of Histopathology
Director of Provider Engagement
Director, Ecosystem Partnerships, Africa